McGregor IS et al. |
A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. |
1998 |
Brain Res. |
pmid:9748483
|
Schneider U et al. |
Cannabinoid/anandamide system and schizophrenia: is there evidence for association? |
1998 |
Pharmacopsychiatry |
pmid:9754842
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Pestonjamasp VK and Burstein SH |
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. |
1998 |
Biochim. Biophys. Acta |
pmid:9795237
|
White R and Hiley CR |
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. |
1998 |
Br. J. Pharmacol. |
pmid:9806337
|
Bisogno T et al. |
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. |
1998 |
Eur. J. Biochem. |
pmid:9688276
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Aceto MD et al. |
Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808686
|
Patel NA et al. |
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. |
1998 |
Brain Res. |
pmid:9666136
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Stefano GB et al. |
Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. |
1998 |
Int. J. Cardiol. |
pmid:9687087
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Qin C et al. |
Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography. |
1998 |
Anal. Biochem. |
pmid:9683506
|
Bisogno T et al. |
Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703957
|
Kondo S et al. |
Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. |
1998 |
Arch. Biochem. Biophys. |
pmid:9637740
|
Stefano GB et al. |
Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641464
|
Stefano GB et al. |
Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641470
|
Stahl SM |
Getting stoned without inhaling: anandamide is the brain's natural marijuana. |
1998 |
J Clin Psychiatry |
pmid:9862600
|
Bonhaus DW et al. |
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9864268
|
Ueda N et al. |
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. |
1998 |
J. Med. Invest. |
pmid:9864962
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Navarro M and RodrÃguez de Fonseca F |
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. |
1998 |
Neurobiol. Dis. |
pmid:9974172
|
Di Marzo V and Deutsch DG |
Biochemistry of the endogenous ligands of cannabinoid receptors. |
1998 |
Neurobiol. Dis. |
pmid:9974173
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|
Maccarrone M et al. |
Anandamide hydrolysis by human cells in culture and brain. |
1998 |
J. Biol. Chem. |
pmid:9822713
|
Derocq JM et al. |
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. |
1998 |
FEBS Lett. |
pmid:9563506
|
van Zadelhoff G et al. |
With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9675081
|
Axelrod J and Felder CC |
Cannabinoid receptors and their endogenous agonist, anandamide. |
1998 |
Neurochem. Res. |
pmid:9566594
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Di Marzo V et al. |
Interactions between synthetic vanilloids and the endogenous cannabinoid system. |
1998 |
FEBS Lett. |
pmid:9801167
|
Van der Kloot W et al. |
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions. |
1998 |
J. Physiol. (Lond.) |
pmid:9508830
|
Stein EA et al. |
Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. |
1998 |
Neuropsychopharmacology |
pmid:9803424
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Randall MD and Kendall DA |
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. |
1998 |
Eur. J. Pharmacol. |
pmid:9617751
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Giuffrida A and Piomelli D |
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
1998 |
FEBS Lett. |
pmid:9498819
|
Tong W et al. |
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. |
1998 |
J. Med. Chem. |
pmid:9784095
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Hampson AJ et al. |
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. |
1998 |
J. Neurochem. |
pmid:9453561
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|
Pratt PF et al. |
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. |
1998 |
Am. J. Physiol. |
pmid:9458889
|
Qureshi J et al. |
Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol. |
1998 |
Mol. Cell. Biochem. |
pmid:9562238
|
Paria BC et al. |
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. |
1998 |
Biol. Reprod. |
pmid:9623610
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|